PL428024A1 - Sulfonated polystyrene derivative for application in treatment and/or prevention of the infection caused by feline herpesvirus - Google Patents

Sulfonated polystyrene derivative for application in treatment and/or prevention of the infection caused by feline herpesvirus

Info

Publication number
PL428024A1
PL428024A1 PL428024A PL42802418A PL428024A1 PL 428024 A1 PL428024 A1 PL 428024A1 PL 428024 A PL428024 A PL 428024A PL 42802418 A PL42802418 A PL 42802418A PL 428024 A1 PL428024 A1 PL 428024A1
Authority
PL
Poland
Prior art keywords
feline herpesvirus
infection caused
treatment
sulfonated polystyrene
polystyrene derivative
Prior art date
Application number
PL428024A
Other languages
Polish (pl)
Other versions
PL239391B1 (en
Inventor
Maria Nowakowska
Krzysztof SZCZUBIAŁKA
Krzysztof PYRĆ
Aleksandra SYNOWIEC
Original Assignee
Uniwersytet Jagielloński
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Jagielloński filed Critical Uniwersytet Jagielloński
Priority to PL428024A priority Critical patent/PL239391B1/en
Priority to CA3121899A priority patent/CA3121899A1/en
Priority to US17/298,777 priority patent/US11857566B2/en
Priority to EP19845729.3A priority patent/EP3890754B1/en
Priority to KR1020267004051A priority patent/KR20260023101A/en
Priority to PCT/PL2019/050071 priority patent/WO2020117080A1/en
Priority to KR1020217018759A priority patent/KR102926435B1/en
Priority to ES19845729T priority patent/ES2938417T3/en
Priority to JP2021527090A priority patent/JP2022509615A/en
Priority to BR112021010775-4A priority patent/BR112021010775A2/en
Publication of PL428024A1 publication Critical patent/PL428024A1/en
Publication of PL239391B1 publication Critical patent/PL239391B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem wynalazku jest sulfonowana pochodna polistyrenu o wzorze I do zastosowania w leczeniu i/lub profilaktyce infekcji wywołanej przez kociego herpeswirusa, w szczególności kociego herpeswirusa typu 1 (FHV-1), jak również taka sulfonowana pochodna polistyrenu do zastosowania w terapii skojarzonej infekcji wywołanej przez kociego herpeswirusa oraz zastosowanie takiej sulfonowanej pochodnej polistyrenu do wytwarzania leku do leczenia i/lub profilaktyki infekcji wywołanej przez kociego herpeswirusa, w szczególności kociego herpeswirusa typu 1.The invention relates to a sulfonated polystyrene derivative of formula I for use in the treatment and / or prophylaxis of infection caused by feline herpesvirus, in particular feline herpesvirus type 1 (FHV-1), as well as such a sulfonated polystyrene derivative for use in the combination therapy of infection caused by feline herpesvirus and the use of such a sulfonated polystyrene derivative in the manufacture of a medicament for the treatment and / or prophylaxis of infection caused by feline herpesvirus, in particular feline herpesvirus type 1.

PL428024A 2018-12-03 2018-12-03 Sulfonated polystyrene derivative for application in treatment and/or prevention of the infection caused by feline herpesvirus PL239391B1 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
PL428024A PL239391B1 (en) 2018-12-03 2018-12-03 Sulfonated polystyrene derivative for application in treatment and/or prevention of the infection caused by feline herpesvirus
CA3121899A CA3121899A1 (en) 2018-12-03 2019-12-03 A sulfonated polystyrene derivative for use in the treatment and/or prophylaxis of cat flu
US17/298,777 US11857566B2 (en) 2018-12-03 2019-12-03 Sulfonated polystyrene derivative for use in the treatment and/or prophylaxis of cat flu
EP19845729.3A EP3890754B1 (en) 2018-12-03 2019-12-03 A sulfonated polystyrene derivative for use in the treatment and/or prophylaxis of cat flu
KR1020267004051A KR20260023101A (en) 2018-12-03 2019-12-03 A sulfonated polystyrene derivative for use in the treatment and/or prophylaxis of cat flu
PCT/PL2019/050071 WO2020117080A1 (en) 2018-12-03 2019-12-03 A sulfonated polystyrene derivative for use in the treatment and/or prophylaxis of cat flu
KR1020217018759A KR102926435B1 (en) 2018-12-03 2019-12-03 Sulfonated polystyrene derivatives for use in the treatment and/or prevention of feline influenza
ES19845729T ES2938417T3 (en) 2018-12-03 2019-12-03 Sulfonated polystyrene derivative for use in the treatment and/or prophylaxis of cat influenza
JP2021527090A JP2022509615A (en) 2018-12-03 2019-12-03 Sulfonized polystyrene derivatives for use in the treatment and / or prevention of feline influenza
BR112021010775-4A BR112021010775A2 (en) 2018-12-03 2019-12-03 SULPHONATED POLYSTYRENE DERIVATIVE FOR USE IN THE TREATMENT AND/OR PROPHYLAXIS OF FELINE FLU

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL428024A PL239391B1 (en) 2018-12-03 2018-12-03 Sulfonated polystyrene derivative for application in treatment and/or prevention of the infection caused by feline herpesvirus

Publications (2)

Publication Number Publication Date
PL428024A1 true PL428024A1 (en) 2020-06-15
PL239391B1 PL239391B1 (en) 2021-11-29

Family

ID=71086952

Family Applications (1)

Application Number Title Priority Date Filing Date
PL428024A PL239391B1 (en) 2018-12-03 2018-12-03 Sulfonated polystyrene derivative for application in treatment and/or prevention of the infection caused by feline herpesvirus

Country Status (1)

Country Link
PL (1) PL239391B1 (en)

Also Published As

Publication number Publication date
PL239391B1 (en) 2021-11-29

Similar Documents

Publication Publication Date Title
JOP20230272A1 (en) RIP1 inhibitors and methods for their preparation and use
MY199353A (en) Methods of treatment using a jak inhibitor compound
MX2022000711A (en) PARP1 INHIBITORS.
SA520412335B1 (en) Oxy-fluoropiperidine derivatives as kinase inhibitor
UA118149C2 (en) Jak inhibitor
EA201990833A1 (en) Pyridine compound
MY196186A (en) Amino-Fluoropiperidine Derivatitves as Kinase Inhibitor
PH12017501958B1 (en) Rsv antiviral pyrazolo- and triazolo-pyrimidine compounds
EA201792116A1 (en) JANUS KINASE INHIBITOR
PH12021500034A1 (en) Compounds useful in hiv therapy
MX2018000396A (en) Substituted aza compounds as irak-4 inhibitors.
MX2018005041A (en) Compounds for treating amyotrophic lateral sclerosis.
EA201991253A1 (en) BENZODIAZOLIUM COMPOUNDS AS ENAC INHIBITORS
MX2023014492A (en) COMPOUNDS USEFUL IN THERAPY FOR HIV.
MX2018008307A (en) Ascochlorin derivative and use thereof as ampk activator.
MX2019006768A (en) Antimicrobial peptides.
PH12019502046A1 (en) Pyrrolotriazine derivatives as kinase inhibitor
WO2019040105A3 (en) Compounds, salts thereof and their use in the treatment of diseases
BR112017021589A2 (en) Methods For Treating Cardiovascular Disorders
MX381234B (en) PREVENTIVE AND/OR THERAPEUTIC AGENT OF IMMUNE DISEASE.
PL428024A1 (en) Sulfonated polystyrene derivative for application in treatment and/or prevention of the infection caused by feline herpesvirus
MX2020009334A (en) Compounds for treating alzheimer's disease.
WO2019040104A3 (en) Compounds, salts thereof and their use for the treatment of diseases
ZA202107710B (en) Isochromene derivatives as phosphoinositide 3-kinases inhibitors
AU2014298561A8 (en) Substituted pyridine-piperazinyl analogues as RSV antiviral compounds